Fund
Xcellerant Ventures
Xcellerant Ventures led the round of Geneticure (1 M$) on 21 October 2026. It is the only health round Bolus has logged for it so far.
Page built from the operations logged, not from a written profile. It says nothing about the fund's activity outside the scope of Bolus, which is health venture capital in Europe and the United States.
Get Xcellerant Ventures's next deals
An email each time this fund appears in a new health deal, plus the Friday newsletter. Nothing else.
Free. One click to unsubscribe. The list is never sold. In French.
- Operations logged
- 1
- Lead
- 1
- New entries
- 0
- Follow ons
- 0
- Latest operation
- 21 October 2026
- Sectors
- Diagnostics
Operations
| Date | Company | Stage | Amount | Role |
|---|---|---|---|---|
| 21 Oct | United States, Diagnostics | 1 M$ | Lead |
Co investors 0 funds crossed
No co investor logged.
Funds that appeared in the same rounds, in any capacity. Geographies logged: United States.